Document is current
Any future updates will be listed below
-
Authors
Oeztuerk, Menekse https://orcid.org/0009-0009-2636-9731
Huntemann, Niklas
Gerischer, Lea
Herdick, Meret
Nelke, Christopher
Stascheit, Frauke
Hoffmann, Sarah
Lehnerer, Sophie
Stein, Maike
Schubert, Charlotte
Schneider-Gold, Christiane
Pfeuffer, Steffen
Krämer, Heidrun H.
Konen, Franz Felix
Skripuletz, Thomas
Pawlitzki, Marc
Rehmann, Robert
Arat, Ercan
Menskes, Christina B.
Glaubitz, Stefanie
Zschüntzsch, Jana
Scherwietes, Valerie
Totzeck, Andreas
Hagenacker, Tim
Meisel, Andreas
Meuth, Sven G.
Ruck, Tobias
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (2023_EKEA.38)
Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
Deutsche Forschungsgemeinschaft (NE 2774/2-1)
Deutsche Forschungsgemeinschaft (549557400/RU 2169/5-1)
Deutsche Forschungsgemeinschaft (417677437/GRK2578)
Deutsche Gesellschaft für Muskelkranke
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 24 December 2025
Revised: 7 February 2026
Accepted: 14 February 2026
First Online: 27 February 2026
Declarations
:
: The authors report no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and complied with the STROBE reporting guidelines. Ethical approval was obtained from the ethics committee of Charité – Universitätsmedizin Berlin (EA1/214/18); patient inclusion at the Hannover site was additionally covered by a separate ethics vote (9741_BO_S_2021). The study was prospectively registered in the WHO-accredited German Clinical Trials Register (DRKS00024099). All participants provided written informed consent within the framework of the German Myasthenia Registry.
: Not applicable.
